ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, will hold its quarterly conference call to discuss fourth quarter and full-year 2013 results on Wednesday, Jan. 22, 2014, at 8 a.m. EST (7 a.m. CST).
A live webcast will be available via the St. Jude Medical Investor Relations website (www.sjm.com/corporate/investor-relations.aspx).
Approximately one hour following the call, a replay will be available under the Investor Events and Presentations page in the Investor Relations section of the St. Jude Medical website.
About St. Jude Medical
St. Jude Medical is a global medical device manufacturer dedicated to transforming the treatment of some of the world’s most expensive, epidemic diseases. The company does this by developing cost-effective medical technologies that save and improve lives of patients around the world. Headquartered in St. Paul, Minn., St. Jude Medical has four major clinical focus areas that include cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. For more information, please visit sjm.com or follow us on Twitter, @StJudeMedicalIR.